Filter by type

Filter by topics

Show More




Results: 267

Sort by: Relevancy |  Date new to old |  Date old to new

  • Re/insurance in the Middle East and Pakistan (2017)

    This report provides an overview of the re/insurance industry in the Middle East and Pakistan. There is a further breakdown of the countries reviewed between those of the Middle East region generally (Egypt, Iran, Jordan, Lebanon, Libya, Syria) and Pakistan, and the member states of the Gulf Cooperation Council (the GCC - Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates). This is because the insurance markets in the GCC states are generally larger and more developed developed than in other countries in the Middle East region. The report is available on request for distribution to Swiss Re clients in hard copy only.
  • Closing the protection gap - Disaster risk financing: Smart solutions for the public sector

    Every year natural and man-made catastrophes cause a distressing loss of lives and considerable economic costs around the world. Both industrialised and developing countries are affected, and surprisingly, both are also materially underinsured. This is the 3rd edition of a Closing the Protection Gap – Smart solutions for the public sector, which outlines various insurance based tools and approaches proven to help governments, regions and cities, and the constituents they represent, to become more resilient.
  • Belt and Road Initiative – 2Q 2018 update

    Read more about the latest developments of the “Belt & Road” (B&R) Initiative and its potential impact on the re/insurance industry.
  • Measuring economic performance & solvency at Swiss Re

    Swiss Re uses its proprietary economic valuation and performance measurement framework (Economic Value Management, EVM) for its business steering with the objective to maximise shareholder value and allocate capital to the most attractive risk pools from an economic risk/return perspective.
  • Critical illness insurance in Canada

    The current product structure of the standalone, fully-guaranteed individual critical illness insurance product was launched in Canada more than 20 years ago. Yet penetration remains low at 3%. Scientific advances and next-generation medical diagnostics could undermine the viability of current CI products due to heightened risk of over-diagnoses and anti-selection. Could changing the current long-term guaranteed model benefit consumers and insurers in Canada alike?
  • Pension schemes in Latin America: addressing the challenges of longevity

    We define the pension gap as the difference between the capital required to replace 65% of the pre-retirement income at the point of retirement, and the capital that is projected to be accumulated under mandatory contribution rates. This Expertise Publication estimates the pension gap in the six largest markets in Latin America - Argentina, Brazil, Chile, Colombia, Mexico and Peru – at USD 2.2 trillion. The paper explores the various options these countries have for closing the pension gap, as well as how the insurance industry can help protect individuals against mortality and longevity risks.
  • ILS market update January 2018

    New issuance slowed dramatically in the second half of the year with only USD 2.13bn of issuance, the lightest total since 2009. Despite this, full-year issuance still exceeded USD 10.0bn, carried by the record shattering first half of the year with USD 8.4bn issuance.
  • Global insurance review 2017 and outlook 2018 /19

    Global growth prospects continued to improve during 2017 and a recession next year is unlikely. Even so, only moderate growth is expected this year, with real gross domestic product (GDP) estimated to increase by slightly more than 2% in the US and Euro area, by about 1.5% in the UK, and by 6.8% in China.
  • The Australian commercial insurance market

    Australia’s commercial insurance market is the ninth largest in the world, with total premiums of USD 12 billion in 2016. However, penetration (premiums as a percentage of gross domestic product (GDP)) is still low relative to other advanced markets. For example, commercial insurance penetration was 0.9% in 2016, compared to 1.6% in the US and 2.4% in the UK.
  • The health insurance frontier in India

    Chronic diseases such as cardiovascular diseases, cancer, and diabetes are on the rise in India. The major drivers behind rising incidence rates are primarily demographic and lifestyle changes. These critical illnesses (CI) are a burden for the Indian population. Being diagnosed with a severe illness puts heavy financial strains on individuals and their families, especially those who are uninsured. Insurers play an important role in raising awareness of existing protection gaps and in helping society to close them. This study demonstrates an approach for deeper insights into the drivers behind consumers' preferences and product choices for CI insurance in India. It focuses on what creates value for consumers and how much they are willing to pay to close their CI protection gap.